Towns <197A> has seen significant continued growth. It has been announced that a basic agreement has been reached between Roche Diagnostics and the company to establish fundamental trade conditions and rights and obligations for the sale of the company’s products to Roche. The products to be sold include Immuno Ace SARS-CoV-2 III specifications: 10 tests, and Immuno Ace SARS-CoV-2/Flu specifications: 10 tests. Moves are being made in anticipation of performance impact due to the expansion of sales to Roche Group companies.
タウンズ---大幅続伸、ロシュ・ダイアグノスティックスと取引契約に関する基本合意締結
Towns --- significantly continued to rise, basic agreement reached regarding the Trade contract with Roche Diagnostics.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated